AOD9604Research compoundARA-290Phase 2ArgirelineResearch compoundBPC-157Research compoundCagrilintidePhase 3CJC-1295Research compoundDihexaPreclinicalEpitalonResearch compoundGHK-CuResearch compoundGHRP-2Research compoundGHRP-6Research compoundHexarelinResearch compoundHumaninPreclinicalIpamorelinResearch compoundKPVResearch compoundLiraglutideApprovedLL-37PreclinicalMatrixylResearch compoundMelanotan IIResearch compoundMOTS-cPreclinicalPT-141ApprovedRetatrutidePhase 3SelankResearch compoundSemaglutideApprovedSemaxResearch compoundSermorelinResearch compoundSS-31Phase 3SurvodutidePhase 3TB-500Research compoundTesamorelinApprovedThymosin Alpha-1ApprovedTirzepatideApprovedAOD9604Research compoundARA-290Phase 2ArgirelineResearch compoundBPC-157Research compoundCagrilintidePhase 3CJC-1295Research compoundDihexaPreclinicalEpitalonResearch compoundGHK-CuResearch compoundGHRP-2Research compoundGHRP-6Research compoundHexarelinResearch compoundHumaninPreclinicalIpamorelinResearch compoundKPVResearch compoundLiraglutideApprovedLL-37PreclinicalMatrixylResearch compoundMelanotan IIResearch compoundMOTS-cPreclinicalPT-141ApprovedRetatrutidePhase 3SelankResearch compoundSemaglutideApprovedSemaxResearch compoundSermorelinResearch compoundSS-31Phase 3SurvodutidePhase 3TB-500Research compoundTesamorelinApprovedThymosin Alpha-1ApprovedTirzepatideApproved
Terminal / Cognitive

Selank

Research compound

aka TP-7

Semax's calmer sibling. An anti-anxiety nootropic, approved in Russia.

Related Compounds